Vertex pauses Moderna-partnered cystic fibrosis trial, takes $379M hit tied to separate program
Fierce Biotech - 06 May 2025Vertex pauses Moderna-partnered cystic fibrosis trial, takes $379M hit tied to separate program ...
vertex
Vertex pauses Moderna-partnered cystic fibrosis trial, takes $379M hit tied to separate program ...
Why Vertex Pharmaceuticals Stock Is Down Sharply
Barron's - 06 May 2025Why Vertex Pharmaceuticals Stock Is Down Sharply ...
Top Stock Movers Now: Vertex, DoorDash, Constellation Energy, and More
Investopedia - 06 May 2025Top Stock Movers Now: Vertex, DoorDash, Constellation Energy, and More ...
Vertex Abandons AAV as Gene Therapy Space Weathers Difficulties
BioSpace - 05 May 2025Vertex Abandons AAV as Gene Therapy Space Weathers Difficulties ...
Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia
Fierce Pharma - 06 May 2025Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia ...
Despite Q1 miss, pain drug launch and new CF therapy drive Vertex growth
The Pharma Letter - 06 May 2025Despite Q1 miss, pain drug launch and new CF therapy drive Vertex growth ...
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
MarketWatch - 06 May 2025Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors ...
Vertex Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
TipRanks - 07 May 2025Vertex Pharmaceuticals’ Earnings Call Highlights Growth and Challenges ...
Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?
Benzinga - 06 May 2025Why Did Vertex Pharmaceuticals Stock Fall On Tuesday? ...
Vertex Pharmaceuticals Incorporated 2025 Q1 - Results - Earnings Call Presentation (NASDAQ:VRTX)
Seeking Alpha - 06 May 2025Vertex Pharmaceuticals Incorporated 2025 Q1 - Results - Earnings Call Presentation (NASDAQ:VRTX) ...
Big-Name Biotech Dives 10% On A Series Of Setbacks
Investor's Business Daily - 06 May 2025Big-Name Biotech Dives 10% On A Series Of Setbacks ...
Vertex reports an earnings miss and pause on cystic fibrosis trial
statnews.com - 05 May 2025Vertex reports an earnings miss and pause on cystic fibrosis trial ...
Vertex Pharmaceuticals Stock Sinks as Costs Soar
Investopedia - 06 May 2025Vertex Pharmaceuticals Stock Sinks as Costs Soar ...
Vertex Sinks On Below-Consensus Revenue, Limited Sales From New Launches
insights.citeline.com - 06 May 2025Vertex Sinks On Below-Consensus Revenue, Limited Sales From New Launches ...
Vertex On Track To Significantly Improve Revenue And Earnings By 2030 (NASDAQ:VRTX)
Seeking Alpha - 07 May 2025Vertex On Track To Significantly Improve Revenue And Earnings By 2030 (NASDAQ:VRTX) ...
Vertex Pharmaceuticals (NasdaqGS:VRTX) Raises Guidance Despite Intangible Asset Impairment Charge
Yahoo Finance - 06 May 2025Vertex Pharmaceuticals (NasdaqGS:VRTX) Raises Guidance Despite Intangible Asset Impairment Charge ...
Vertex Study: Global Tax and Finance Leaders Significantly Shift in Support of e-Invoicing
GlobeNewswire - 06 May 2025Vertex Study: Global Tax and Finance Leaders Significantly Shift in Support of e-Invoicing ...
Vertex Study: e-Invoicing Benefits Exceed Challenges for 80% of North American Businesses
CPA Practice Advisor - 06 May 2025Vertex Study: e-Invoicing Benefits Exceed Challenges for 80% of North American Businesses ...
Vertex misses quarterly results on weaker-than-expected sales for cystic fibrosis drug
Reuters - 05 May 2025Vertex misses quarterly results on weaker-than-expected sales for cystic fibrosis drug ...